SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share (SLS)

CUSIP: 81642T209

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
152,677,102
Total 13F shares
1,688,629
Share change
-47,153
Total reported value
$11,276,000
Put/Call ratio
68%
Price per share
$6.68
Number of holders
25
Value change
-$279,247
Number of buys
10
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 81642T209?
CUSIP 81642T209 identifies SLS - SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share (SLS) as of Q1 2022

As of 31 Mar 2022, SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share (SLS) was held by 25 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,688,629 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, Equitable Holdings, Inc., SUSQUEHANNA INTERNATIONAL GROUP, LLP, AMERIPRISE FINANCIAL INC, MORGAN STANLEY, STATE STREET CORP, PRELUDE CAPITAL MANAGEMENT, LLC, and NORTHERN TRUST CORP. This page lists 25 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.